Last reviewed · How we verify
GW842166
At a glance
| Generic name | GW842166 |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- An Imaging Study to Investigate the Distribution of GW842166X in the Brain. (PHASE1)
- A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis (PHASE2)
- Dose Response and Efficacy of GW842166 in Pain (PHASE1)
- Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects. (PHASE1)
- A Study of GW842166 in Adults With Osteoarthritis Pain (PHASE2)
- Dental Pain 3rd Molar Tooth Extraction GW842166 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |